Biogen Inc (NASDAQ:BIIB) under-valued by 10%
Website | https://www.biogen.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $42,418,872,320 |
Beta | 0.436845 |
Average Volume | $1,088,167 |
Last Dividend | 0% |
Price on May 3, 2022 | $202.22 |
Autochartist™ Valuation | $223.23 |
Conclusion |
10% under-valued |
Download Report |